Table 3

Relationship between clinicopathological features and AAH groups

Features Total AAH(−) AAH(+) (single/multiple) OR (95% CI)3-150
No of cases508390118  (71/47)
Sex
 Male32425767 (38/29)1.47 (0.97 to 2.24)
 Female18413351 (33/18)
Age (years)
 ⩾6525219359 (38/21)1.02 (0.68 to 1.54)
 <6525619759 (33/26)
Smoking status
 Never smokers16712740 (26/14)1.06 (0.69 to 1.64)
 Smokers34126378 (45/33)
 Ex-smokers12810028 (16/12)
  ⩽20 pack-years smoked291910 (4/6)
  >20 pack-years smoked998118 (12/6)
 Current smokers21316350 (29/21)
  ⩽20 pack-years smoked17116 (4/2)
  >20 pack-years smoked19615244 (25/19)
Histology3-151
 Adenocarcinoma32823296 (54/42)2.97 (1.82 to 4.85)
 Non-adenocarcinoma18015822 (17/5)
  Squamous12211012 (9/3)
  Large cell17152 (1/1)
  Small cell13121 (1/0)
  Adenosquamous28217 (6/1)
 No. of lung carcinoma
  Single473371102 (65/37)3.06 (1.56 to 6.00)
  Multiple351916 (6/10)
  • AAH = atypical adenomatous hyperplasia.

  • 3-150 AAH (−) group v AAH (+) groups (logistic regression).

  • 3-151 In cases of multiple carcinoma the histological type of the largest tumour was used.